Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pappas

Showing results (411-420 of 605) with videos related to

Pageof 61
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2018
Impact of Infectious Disease Consultation on Clinical Management and Mortality in Patients With CandidemiaRachael A Lee, Joanna C Zurko, Bernard C Camins, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998M E Brandt, M A Pfaller, R A Hajjeh, et al.
Annals of Surgical Oncology|October 26, 2018
Increased SOX9 Expression in Premalignant and Malignant Pancreatic NeoplasmsJennifer L Gnerlich, Xianzhong Ding, Cara Joyce, et al.
Clinical and Experimental Immunology|July 24, 2004
Anti-actin IgA antibodies in severe coeliac diseaseA Granito, P Muratori, F Cassani, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitisRobert A Larsen, Peter G Pappas, John Perfect, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 3, 2012
Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected personsJ A McKinnell, A P Cannella, D F Kunz, et al.
Infectious Diseases and Therapy|June 18, 2022
Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal InfectionsL Ostrosky-Zeichner, M H Nguyen, J Bubalo, et al.
Infection Control and Hospital Epidemiology|January 4, 2008
Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis Douglas C Chang, Lauren A Burwell, G Marshall Lyon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2014
Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases GroupRaoul Herbrecht, Thomas F Patterson, Monica A Slavin, et al.
Journal of the American Chemical Society|February 6, 2020
Spontaneous Emergence of Self-Replicating Molecules Containing Nucleobases and Amino AcidsBin Liu, Charalampos G Pappas, Jim Ottelé, et al.
Pageof 61

Showing results (411-420 of 605) with videos related to

Sort By:
Pageof 61
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2018
Impact of Infectious Disease Consultation on Clinical Management and Mortality in Patients With CandidemiaRachael A Lee, Joanna C Zurko, Bernard C Camins, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998M E Brandt, M A Pfaller, R A Hajjeh, et al.
Annals of Surgical Oncology|October 26, 2018
Increased SOX9 Expression in Premalignant and Malignant Pancreatic NeoplasmsJennifer L Gnerlich, Xianzhong Ding, Cara Joyce, et al.
Clinical and Experimental Immunology|July 24, 2004
Anti-actin IgA antibodies in severe coeliac diseaseA Granito, P Muratori, F Cassani, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitisRobert A Larsen, Peter G Pappas, John Perfect, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 3, 2012
Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected personsJ A McKinnell, A P Cannella, D F Kunz, et al.
Infectious Diseases and Therapy|June 18, 2022
Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal InfectionsL Ostrosky-Zeichner, M H Nguyen, J Bubalo, et al.
Infection Control and Hospital Epidemiology|January 4, 2008
Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis Douglas C Chang, Lauren A Burwell, G Marshall Lyon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2014
Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases GroupRaoul Herbrecht, Thomas F Patterson, Monica A Slavin, et al.
Journal of the American Chemical Society|February 6, 2020
Spontaneous Emergence of Self-Replicating Molecules Containing Nucleobases and Amino AcidsBin Liu, Charalampos G Pappas, Jim Ottelé, et al.
Pageof 61